Amanta Healthcare Share Price Sees Strong Market Debut on Stock Market Today

Market Performance

Amanta Healthcare share price made a confident debut in the stock market today, September 9. The stock listed on the NSE at ₹135 per share, reflecting a 7.14% premium over its issue price of ₹126. On the BSE, the debut was equally strong, with the scrip opening at ₹134 per share, up 6.35% from its IPO price.

This performance highlights the robust demand witnessed during the IPO process, setting the tone for Amanta Healthcare’s journey in the public markets.

Main News: IPO Listing Highlights

The Amanta Healthcare IPO opened for subscription on September 1 and closed on September 3, with allotments finalized by September 4. The company officially entered the bourses on September 9, marking a milestone for both the firm and its investors.

Key IPO highlights:

• Issue Size: ₹126 crore (entirely fresh issue)
• Equity Shares Offered: 1 crore
• Retail Lot Size: 119 shares (minimum investment ₹14,994)

The IPO saw unprecedented participation, making it one of the most talked-about listings in recent times.

Company Details and Investor Response

Investor sentiment around Amanta Healthcare IPO was exceptionally strong. Data reflects the depth of demand:

• Overall Subscription: 82.61 times
• Retail Investors: 54.98 times
• Non-Institutional Investors (NIIs): 209.42 times
• Qualified Institutional Buyers (QIBs): 35.86 times

Such widespread participation across categories underscores the confidence investors have in the company’s fundamentals and growth prospects.

Use of IPO Proceeds

Amanta Healthcare plans to channel the funds raised into capacity expansion and infrastructure. The capital will be utilized for:

• Civil construction and equipment procurement for its SteriPort manufacturing line at Hariyala, Kheda, Gujarat.
• Setting up a new SVP manufacturing line at the same facility.
• General corporate purposes, ensuring operational strength and future readiness.

About Amanta Healthcare

Founded in December 1994, Amanta Healthcare Limited has established itself as a key player in the pharmaceutical industry, with a sharp focus on sterile liquid products. The company’s expertise lies in parenteral solutions produced through advanced technologies such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM).

Its diversified product range includes:

• IV fluids
• Diluents
• Ophthalmic solutions
• Respiratory care products
• Irrigation solutions
• First-aid essentials
• Eye lubricants under its medical devices division

This broad portfolio ensures the company’s presence across critical healthcare segments.

Summary

• Amanta Healthcare share price listed at ₹135 on NSE and ₹134 on BSE, posting a strong debut with a 7% premium.
• The ₹126 crore IPO was oversubscribed 82.61 times, led by robust retail and NII participation.
• Proceeds will fuel new manufacturing lines and facility expansion in Gujarat.
• The company, established in 1994, specializes in sterile liquid products and has a diverse healthcare-focused portfolio.

Amanta Healthcare’s listing reflects both strong market sentiment and investor appetite, making it a noteworthy debut in the stock market today.